Vivani Medical (VANI) News Today $1.18 0.00 (0.00%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Vivani begins exenatide implant trial for obesity in AustraliaDecember 20 at 8:41 AM | finance.yahoo.comVivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in AustraliaDecember 19 at 10:28 AM | finance.yahoo.comVivani Medical, Inc. (NASDAQ:VANI) Short Interest Down 29.6% in NovemberVivani Medical, Inc. (NASDAQ:VANI - Get Free Report) was the recipient of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 531,000 shares, a decline of 29.6% from the October 31st total of 754,400 shares. Based on an average trading volume of 100,300 shares, the short-interest ratio is presently 5.3 days. Currently, 1.9% of the shares of the company are sold short.November 29, 2024 | marketbeat.comVivani Medical Gains ‘Buy’ Rating Due to Strategic Advancements and Financial StrengthNovember 15, 2024 | markets.businessinsider.comVivani Medical Reports Q3 Loss, Advances GLP-1 TrialsNovember 14, 2024 | markets.businessinsider.comVivani Medical, Inc. (NASDAQ:VANI) Director Buys $4,999,998.78 in StockNovember 14, 2024 | insidertrades.comVivani Medical Secures Funding for GLP-1 Implant TrialNovember 14, 2024 | markets.businessinsider.comVivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | finance.yahoo.comVivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams Purchases 3,968,253 SharesVivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams acquired 3,968,253 shares of the company's stock in a transaction dated Friday, November 8th. The shares were bought at an average cost of $1.26 per share, with a total value of $4,999,998.78. Following the purchase, the director now owns 4,695,861 shares in the company, valued at approximately $5,916,784.86. The trade was a 500.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.November 13, 2024 | marketbeat.com3 US Penny Stocks To Monitor In October 2024October 23, 2024 | finance.yahoo.comVivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024October 23, 2024 | finance.yahoo.comVivani Medical (NASDAQ:VANI) Trading Up 0.9% - Time to Buy?Vivani Medical (NASDAQ:VANI) Stock Price Up 0.9% - What's Next?October 15, 2024 | marketbeat.comVivani Medical's implant trial gets Australian regulatory nodSeptember 28, 2024 | uk.investing.comBuy Rating on Vivani Medical: Advancing GLP-1 Therapies with Innovative Implantable TreatmentSeptember 28, 2024 | markets.businessinsider.comVivani Medical to Test Implant in Obese and Overweight PatientsSeptember 27, 2024 | finance.yahoo.comVivani Medical obtains Australian approval to begin GLP-1 implant trialSeptember 27, 2024 | finance.yahoo.comEXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in AustraliaSeptember 26, 2024 | benzinga.comBuy Rating Affirmed for Vivani Medical on Strong Potential of NPM-115 Implant for Metabolic Disease TreatmentSeptember 7, 2024 | markets.businessinsider.comVivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 ImplantSeptember 4, 2024 | finance.yahoo.comVivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceAugust 28, 2024 | finance.yahoo.comInnovative Obesity Treatment Promises High Compliance: Buy Recommendation for Vivani MedicalAugust 15, 2024 | markets.businessinsider.comHere's Why We're Watching Vivani Medical's (NASDAQ:VANI) Cash Burn SituationAugust 14, 2024 | finance.yahoo.comVANI Stock Earnings: Vivani Medical Beats EPS for Q2 2024August 13, 2024 | markets.businessinsider.comVivani Medical Provides Business Update and Reports Second Quarter 2024 Financial ResultsAugust 13, 2024 | finance.yahoo.comVivani Medical's chief business officer buys $1.92k in company stockAugust 3, 2024 | investing.comVivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug ImplantJune 13, 2024 | businesswire.comEXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary UseMay 28, 2024 | msn.comVivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 ImplantMay 28, 2024 | businesswire.comBuy Rating Justified: Vivani Medical’s Promising NPM-115 Implant and Strategic Market PositioningMay 16, 2024 | markets.businessinsider.comVANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024May 13, 2024 | investorplace.comVivani Medical Provides Business Update and Reports First Quarter 2024 Financial ResultsMay 13, 2024 | businesswire.comVivani Medical to Present at TIDES Conference 2024May 9, 2024 | finance.yahoo.comShort Interest in Vivani Medical, Inc. (NASDAQ:VANI) Expands By 420.1%Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 938,800 shares, an increase of 420.1% from the February 29th total of 180,500 shares. Based on an average daily volume of 2,970,000 shares, the days-to-cover ratio is currently 0.3 days. Currently, 3.4% of the shares of the stock are short sold.March 27, 2024 | marketbeat.comVivani Medical: Q4 Earnings SnapshotMarch 26, 2024 | sfgate.comVivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 26, 2024 | finance.yahoo.comVivani Medical Inc (VANI) Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 26, 2024 | finance.yahoo.comVANI Stock Earnings: Vivani Medical Beats EPS for Q4 2023March 26, 2024 | investorplace.comVANI May 2024 6.000 callMarch 16, 2024 | finance.yahoo.comVANI Aug 2024 6.000 callMarch 16, 2024 | finance.yahoo.comVANI Apr 2024 1.000 callMarch 16, 2024 | finance.yahoo.comThinking about buying stock in Ocean Biomedical, Rush Street Interactive, Vivani Medical, Abeona Therapeutics, or Honest Company?March 9, 2024 | morningstar.comVivani Medical Appoints Daniel Bradbury to its Board of DirectorsMarch 6, 2024 | finance.yahoo.comVivani Medical Surges on its Ozempic-Like Weight-Loss ImplantThe Ozempic craze continues to make headlines in the medical sector, and GLP-1 drug stocks continue to surge higher. Shares of Ozempic and Wegovy makers Novo Nordisk A/S NYSE: NVO are already up 20% year-to-date (YTD).March 6, 2024 | marketbeat.comVivani Medical Surges on its Ozempic-Like Weight-Loss ImplantThe Ozempic craze continues to make headlines in the medical sector, and GLP-1 drug stocks such as Vivani Medical continue to surge higherMarch 6, 2024 | marketbeat.comVivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare moversMarch 4, 2024 | msn.comVANI Mar 2024 2.500 putMarch 3, 2024 | finance.yahoo.comVivani Medical announces pricing of $15M registered direct offeringMarch 1, 2024 | msn.comVivani Medical Shares Retreat 20% on Securities Purchase AgreementMarch 1, 2024 | marketwatch.comVivani Medical Prices $15 Mln Direct Offering; Stock Down Over 20% In Pre-marketMarch 1, 2024 | markets.businessinsider.comVivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and WarrantsMarch 1, 2024 | businesswire.com Get Vivani Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter. Email Address 70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << VANI Media Mentions By Week VANI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VANI News Sentiment▼-0.240.60▲Average Medical News Sentiment VANI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VANI Articles This Week▼21▲VANI Articles Average Week Get Vivani Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SMTI News Today ZYXI News Today LUNG News Today ELMD News Today CATX News Today PROF News Today DRTS News Today SKIN News Today KRMD News Today SGHT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VANI) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivani Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
